David A. Siegel Abb Vie Inc. Transaction History

Two Sigma Advisers, LP

$43.8 Billion
Q2 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Abb Vie Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 250,244 shares of ABBV stock, worth $48 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

250,244

Previous 466,744 46.39%

Holding current value

$48 Million

Previous $85 Million 49.5%

% of portfolio

0.1%

Previous 0.2%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $33.5 Million - $39.1 Million	-216,500 Reduced 46.39%	250,244 $42.9 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $92.2 Million - $105 Million	-577,200 Reduced 55.29%	466,744 $85 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $59.3 Million - $66.8 Million	-431,200 Reduced 29.23%	1,043,944 $162 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $33.1 Million - $38.4 Million	248,100 Added 20.22%	1,475,144 $220 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $69.9 Million - $87 Million	527,600 Added 75.43%	1,227,044 $165 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $96.4 Million - $111 Million	666,600 Added 2029.59%	699,444 $111 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $22.1 Million - $26.6 Million	-160,122 Reduced 82.98%	32,844 $5.31 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $20.4 Million - $23.4 Million	-152,000 Reduced 44.06%	192,966 $25.9 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $255 Million - $324 Million	-1,853,978 Reduced 84.31%	344,966 $52.8 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $12.2 Million - $15.2 Million	92,778 Added 4.41%	2,198,944 $356 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $183 Million - $232 Million	1,704,209 Added 423.98%	2,106,166 $285 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $218 Million - $247 Million	-2,044,510 Reduced 83.57%	401,957 $43.4 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $112 Million - $125 Million	-1,063,000 Reduced 30.29%	2,446,467 $276 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $15.4 Million - $16.9 Million	-150,500 Reduced 4.11%	3,509,467 $380 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $55.6 Million - $75 Million	-690,622 Reduced 15.87%	3,659,967 $392 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $14.9 Million - $17.4 Million	173,002 Added 4.14%	4,350,589 $381 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $116 Million - $155 Million	1,576,465 Added 60.61%	4,177,587 $410 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $201 Million - $304 Million	-3,109,300 Reduced 54.45%	2,601,122 $198 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $41.8 Million - $52.3 Million	-579,900 Reduced 9.22%	5,710,422 $506 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $22.5 Million - $27.1 Million	357,800 Added 6.03%	6,290,322 $476 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $57.3 Million - $73.2 Million	872,100 Added 17.23%	5,932,522 $431 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $291 Million - $342 Million	3,772,100 Added 292.79%	5,060,422 $408 Million
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $3.33 Million - $4.11 Million	42,770 Added 3.43%	1,288,322 $119 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $41.6 Million - $46.2 Million	467,699 Added 60.13%	1,245,552 $118 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $38.2 Million - $45.2 Million	-425,399 Reduced 35.35%	777,853 $72.1 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $35.2 Million - $47.2 Million	383,025 Added 46.7%	1,203,252 $114 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $22 Million - $24.1 Million	245,498 Added 42.72%	820,227 $79.3 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $40.1 Million - $51.3 Million	574,729	574,729 $51.1 Million

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $339B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account